@article{2ea20c8e5959411dad7215689b03ad03,
title = "Correction: Efficacy and safety of brolucizumab versus aflibercept in eyes with early persistent retinal fluid: 96-week outcomes from the HAWK and HARRIER studies (Eye, (2022), 10.1038/s41433-022-02092-5)",
abstract = "The article “Efficacy and safety of brolucizumab versus aflibercept in eyes with early persistent retinal fluid: 96-week outcomes from the HAWK and HARRIER studies”, written by David R. Lally, Anat Loewenstein, Jennifer J. Arnold, Yit C. Yang, Kinfemichael Gedif, Catherine Best, Hersh Patel, Ramin Tadayoni, Jeffrey S. Heier, was originally published electronically on the publisher{\textquoteright}s internet portal on 21 May 2022 without open access.",
author = "Lally, {David R.} and Anat Loewenstein and Arnold, {Jennifer J.} and Yang, {Yit C.} and Kinfemichael Gedif and Catherine Best and Hersh Patel and Ramin Tadayoni and Heier, {Jeffrey S.}",
note = "Publisher Copyright: {\textcopyright} 2022, The Author(s).",
year = "2022",
doi = "10.1038/s41433-022-02130-2",
language = "אנגלית",
journal = "Eye",
issn = "0950-222X",
publisher = "Nature Publishing Group",
}